Virtual screening of new targets and inhibitors for Candida albicans infection control

Infection by Candida albicans fungus is considered of biomedical interest, producing significant mortality and comorbidity. The development of pathogen resistance during pharmacological treatments is increasing, thus, the pursuit for new inhibitors is necessary. Virtual screening is one of the bioin...

Full description

Autores:
Torres-Osorio, Lenin
Munera-Gomez, Marlon
Fennix-Agudelo, Mary
Chavarro-Mesa, Edisson
Tipo de recurso:
Fecha de publicación:
2021
Institución:
Universidad Tecnológica de Bolívar
Repositorio:
Repositorio Institucional UTB
Idioma:
eng
OAI Identifier:
oai:repositorio.utb.edu.co:20.500.12585/12126
Acceso en línea:
https://hdl.handle.net/20.500.12585/12126
Palabra clave:
Bioinformatics
Candidiasis
Drug treatment
Molecular docking
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/4.0/
Description
Summary:Infection by Candida albicans fungus is considered of biomedical interest, producing significant mortality and comorbidity. The development of pathogen resistance during pharmacological treatments is increasing, thus, the pursuit for new inhibitors is necessary. Virtual screening is one of the bioinformatics tools used for the search of new drugs, and potential targets for disease management. The aim of the present study was to analyze a library of potential targets, and to identify suppressors for C. albicans using virtual screening. 50 protein targets with restraining potential were examined, choosing GPI-Anchored hemophore PGA10 protein (RBT5) as the target, since it is involved in C. albicans survival and nutrients acquisition. Meanwhile, through the implementation of AutoDock Vina and PyRx software, the molecular affinity of 25 molecules available in ZINC15 database was analyzed, obtaining favorable results for the following compounds: ZINC000000065058, ZINC000000065374 and ZINC000000072389, displaying affinity with the same region of the target protein. These results provide a potential target for the development of novel suppressors, as well as guidelines for three new drugs that could aid in C. albicans suppression